Avity Investment Management Inc. Bristol Myers Squibb CO Transaction History

Avity Investment Management Inc.

$1.25 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $3.16 Million - $3.51 Million	-49,609 Reduced 92.99%	3,741 $239,000
Q1 2023 Apr 18, 2023	SELL	$65.71 - $74.53 $1.26 Million - $1.43 Million	-19,137 Reduced 26.4%	53,350 $3.7 Million
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $1.78 Million - $2.11 Million	-26,050 Reduced 26.44%	72,487 $5.22 Million
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $13,216 - $7.81 Million	-101,667 Reduced 50.78%	98,537 $7.01 Million
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $4.86 Million - $5.35 Million	-66,879 Reduced 25.04%	200,204 $15.4 Million
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $1.02 Million - $1.22 Million	16,555 Added 6.61%	267,083 $19.5 Million
Q4 2021 Jan 14, 2022	SELL	$53.63 - $62.52 $2.4 Million - $2.8 Million	-44,713 Reduced 15.14%	250,528 $15.6 Million
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $248,809 - $291,448	4,205 Added 1.44%	295,241 $17.5 Million
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $470,825 - $512,729	7,605 Added 2.68%	291,036 $19.4 Million
Q1 2021 Apr 15, 2021	BUY	$59.34 - $66.74 $1.44 Million - $1.62 Million	24,282 Added 9.37%	283,431 $17.9 Million
Q4 2020 Jan 15, 2021	BUY	$57.74 - $65.43 $3.03 Million - $3.44 Million	52,550 Added 25.44%	259,149 $16.1 Million
Q3 2020 Oct 08, 2020	BUY	$57.43 - $63.64 $7.49 Million - $8.3 Million	130,435 Added 171.26%	206,599 $12.5 Million
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $3.82 Million - $4.47 Million	69,685 Added 1075.55%	76,164 $4.48 Million
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $64,155 - $76,065	-1,500 Reduced 18.8%	6,479 $329,000
Q2 2019 Jul 22, 2019	BUY	$44.62 - $49.34 $13,386 - $14,802	300 Added 3.91%	7,979 $362,000
Q1 2019 Apr 12, 2019	SELL	$45.12 - $53.8 $46,022 - $54,876	-1,020 Reduced 11.73%	7,679 $366,000
Q4 2018 Jan 22, 2019	SELL	$48.76 - $63.23 $4,876 - $6,323	-100 Reduced 1.14%	8,699 $452,000
Q3 2018 Oct 18, 2018	BUY	$55.19 - $62.25 $6,622 - $7,470	120 Added 1.38%	8,799 $546,000
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $48,003 - $59,831	950 Added 12.29%	8,679 $480,000
Q1 2018 Apr 19, 2018	BUY	$59.92 - $68.98 $5,992 - $6,898	100 Added 1.31%	7,729 $489,000
Q4 2017 Jan 10, 2018	BUY	$59.94 - $65.35 $95,304 - $103,906	1,590 Added 26.33%	7,629 $468,000
Q3 2017 Oct 20, 2017	BUY	$55.23 - $63.74 $333,533 - $384,925	6,039	6,039 $385,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avity Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avity Investment Management Inc. with notifications on news.

Account